Know a great AI tool or AI news source? Submit it to AiByts
Venture capital4 min read

AI drug development startup Pathos AI closes $237M investment

Pathos AI Inc. today announced that it has raised $237 million in funding at a $3 billion valuation. Pharmaceutical giant Bristol Myers Squibb Co. led the Series E round with participation from several unnamed returning backers.

By Maria DeutscherSiliconANGLE
AI drug development startup Pathos AI closes $237M investment

Read the full story

Originally published by SiliconANGLE on Oct 23, 2026.

Read on SiliconANGLE(opens in a new tab)

Comments

Sign in to join the discussion.

No comments yet — be the first to share your thoughts.